Affiliation:
1. Faculty of Physical Engineering, Novosibirsk State Technical University, 630073 Novosibirsk, Russia
2. Department of Natural Sciences, Novosibirsk State University, 630090 Novosibirsk, Russia
Abstract
Inflammatory bowel disease (IBD) is a multifactorial disease involving the interaction of the gut microbiota, genes, host immunity, and environmental factors. Dysbiosis in IBD is associated with pathobiont proliferation, so targeted antibiotic therapy is a rational strategy. When restoring the microbiota with probiotics, it is necessary to take into account the mutual influence of co-cultivated microorganisms, as the microbiota is a dynamic community of species that mediates homeostasis and physiological processes in the intestine. The aim of our study was to investigate the recovery efficacy of two potential probiotic bacteria, L. johnsonii and E. faecalis, in Muc2−/− mice with impaired mucosal layer. Two approaches were used to determine the efficacy of probiotic supplementation in mice with dysbiosis caused by mucin-2 deficiency: bacterial seeding on selective media and real-time PCR analysis. The recovery time and the type of probiotic bacteria relocated affected only the number of E. faecalis. A significant positive correlation was found between colony-forming unit (CFU) and the amount of E. faecalis DNA in the group that was replanted with probiotic E. faecalis. As for L. johnsonii, it could be restored to its original level even without any additional bacteria supplementation after two weeks. Interestingly, the treatment of mice with L. johnsonii caused a decrease in the amount of E. faecalis. Furthermore, either L. johnsonii or E. faecalis treatment eliminated protozoan overgrowth caused by antibiotic administration.
Funder
Novosibirsk State Technical University
Russian Science Foundation
Reference31 articles.
1. Prevalence of Intestinal Protozoan Infection in Patients with Ulcerative Colitis (UC) in Isfahan, Iran;Pestechian;Int. J. Prev. Med.,2021
2. Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease;Norman;Cell,2015
3. Graves, K.J., Reily, C., Tiwari, H.K., Srinivasasainagendra, V., Secor, W.E., Novak, J., and Muzny, C.A. (2023). Identification of Trichomonas Vaginalis 5-Nitroimidazole Resistance Targets. Pathogens, 12.
4. The Tricky Trichomonas: A Tale of Resistance;Nelson;Am. J. Obstet. Gynecol.,2019
5. Achasova, K.M., Kozhevnikova, E.N., Borisova, M.A., and Litvinova, E.A. (2021). Fucose Ameliorates Tritrichomonas Sp.-Associated Illness in Antibiotic-Treated Muc2−/− Mice. Int. J. Mol. Sci., 22.